+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunoprophylaxis of pseudomonas aeruginosa burn wound sepsis with a cross reactive human monoclonal antibody



Immunoprophylaxis of pseudomonas aeruginosa burn wound sepsis with a cross reactive human monoclonal antibody



Abstracts of the Annual Meeting of the American Society for Microbiology 88: 126




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028487268

Download citation: RISBibTeXText


Related references

Protection studies in a mouse burn wound sepsis model with a human anti pseudomonas aeruginosa flagella monoclonal antibody and its fab 2 and fab fragments. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 123, 1990

Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model. Burns 35(3): 390-396, 2009

Protection against pseudomonas aeruginosa pa sepsis in burned mice with cross reactive monoclonal antibody mca. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 49, 1988

Immunoprophylaxis of polymicrobic cellulitis with a human monoclonal antibody against lipopolysaccharide antigen of pseudomonas aeruginosa. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 137, 1989

Prophylaxis of pseudomonas aeruginosa burn wound sepsis with ciprofloxacin and pseudomonas hyperimmune immunoglobulin g. Abstracts of the Annual Meeting of the American Society for Microbiology 85: 4, 1985

Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Vaccine 23(25): 3264-3271, 2005

Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection. Journal of Medical Microbiology 27(3): 179-190, 1988

Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection. Plos one 9(2): E90494, 2014

The role of fibronectin in pseudomonas aeruginosa burn wound sepsis in the rat. American Association for the Advancement of Science Abstracts of Papers of the National Meeting 148: 135-136, 1982

Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice. Clinical and Diagnostic Laboratory Immunology 6(4): 537-541, 1999

Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound sepsis. Infection and Immunity 25(3): 828-830, 1979

Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes. Official Gazette of the United States Patent & Trademark Office Patents 1198(1): 388, 1997

Bacterial motility: a component in experimental Pseudomonas aeruginosa burn wound sepsis. Burns 6(4): 235-239, 1980

Evidence for a lethal toxin in experimental pseudomonas aeruginosa burn wound sepsis. Abstracts of the Annual Meeting of the American Society for Microbiology 75: 16, 1975

Decreased virulence in experimental burn wound sepsis associated with motility mutants of pseudomonas aeruginosa. Abstracts of the Annual Meeting of the American Society for Microbiology 78 : 28, 1978